These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats. Oliveira LA; Almeida J; Benini R; Crestani CC Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333 [TBL] [Abstract][Full Text] [Related]
3. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. Henry B; Vale W; Markou A J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071 [TBL] [Abstract][Full Text] [Related]
4. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207 [TBL] [Abstract][Full Text] [Related]
5. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity. Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804 [TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History. Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931 [TBL] [Abstract][Full Text] [Related]
7. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476 [TBL] [Abstract][Full Text] [Related]
9. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549 [TBL] [Abstract][Full Text] [Related]
10. Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain. Tran L; Schulkin J; Greenwood-Van Meerveld B Neuropsychopharmacology; 2014 Oct; 39(11):2633-45. PubMed ID: 24853772 [TBL] [Abstract][Full Text] [Related]
11. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats. Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861 [TBL] [Abstract][Full Text] [Related]
12. Similar effect of CRF Spinieli RL; Leite-Panissi CRA Brain Res Bull; 2018 Mar; 137():187-196. PubMed ID: 29246866 [TBL] [Abstract][Full Text] [Related]
13. Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. Liu J; Yu B; Orozco-Cabal L; Grigoriadis DE; Rivier J; Vale WW; Shinnick-Gallagher P; Gallagher JP J Neurosci; 2005 Jan; 25(3):577-83. PubMed ID: 15659593 [TBL] [Abstract][Full Text] [Related]
14. Involvement of CRF2 receptor in the brain regions in restraint-induced anorexia. Ohata H; Shibasaki T Neuroreport; 2011 Jul; 22(10):494-8. PubMed ID: 21666520 [TBL] [Abstract][Full Text] [Related]
15. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Smagin GN; Howell LA; Ryan DH; De Souza EB; Harris RB Neuroreport; 1998 May; 9(7):1601-6. PubMed ID: 9631473 [TBL] [Abstract][Full Text] [Related]
16. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze. Cipriano AC; Gomes KS; Nunes-de-Souza RL Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334 [TBL] [Abstract][Full Text] [Related]
17. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406 [TBL] [Abstract][Full Text] [Related]
18. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Sahuque LL; Kullberg EF; Mcgeehan AJ; Kinder JR; Hicks MP; Blanton MG; Janak PH; Olive MF Psychopharmacology (Berl); 2006 May; 186(1):122-32. PubMed ID: 16568282 [TBL] [Abstract][Full Text] [Related]
19. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic. Sergio Tde O; Spiacci A; Zangrossi H Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701 [TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]